
United States Antimony Co. (NYSEAMERICAN:UAMY – Free Report) – William Blair decreased their FY2025 earnings per share estimates for United States Antimony in a report released on Thursday, November 13th. William Blair analyst N. Dingmann now forecasts that the company will post earnings per share of ($0.02) for the year, down from their previous estimate of $0.04. William Blair has a “Outperform” rating on the stock. The consensus estimate for United States Antimony’s current full-year earnings is ($0.01) per share.
United States Antimony (NYSEAMERICAN:UAMY – Get Free Report) last released its quarterly earnings results on Wednesday, November 12th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $8.70 million for the quarter. United States Antimony had a negative return on equity of 16.58% and a negative net margin of 45.32%. United States Antimony has set its FY 2026 guidance at EPS. FY 2025 guidance at EPS.
Check Out Our Latest Stock Analysis on United States Antimony
United States Antimony Trading Up 3.4%
UAMY opened at $7.08 on Monday. United States Antimony has a fifty-two week low of $0.58 and a fifty-two week high of $19.71. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.24 and a quick ratio of 5.84. The firm has a market capitalization of $983.26 million, a price-to-earnings ratio of -177.00 and a beta of -0.10. The company’s 50 day moving average price is $8.52 and its two-hundred day moving average price is $5.11.
Insider Transactions at United States Antimony
In other news, CEO Gary C. Evans purchased 100,000 shares of the business’s stock in a transaction on Friday, September 26th. The shares were acquired at an average price of $6.13 per share, with a total value of $613,000.00. Following the completion of the transaction, the chief executive officer owned 2,378,818 shares of the company’s stock, valued at $14,582,154.34. The trade was a 4.39% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 4.20% of the stock is currently owned by insiders.
Institutional Investors Weigh In On United States Antimony
Large investors have recently bought and sold shares of the stock. Truist Financial Corp boosted its position in shares of United States Antimony by 14.1% during the 2nd quarter. Truist Financial Corp now owns 2,028,818 shares of the company’s stock worth $4,423,000 after purchasing an additional 250,000 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in United States Antimony by 36.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 359,692 shares of the company’s stock worth $791,000 after buying an additional 95,811 shares during the period. OMERS ADMINISTRATION Corp bought a new position in United States Antimony in the first quarter worth approximately $436,000. CW Advisors LLC bought a new position in United States Antimony in the first quarter worth approximately $352,000. Finally, Penbrook Management LLC acquired a new stake in United States Antimony in the second quarter valued at approximately $44,000. 9.49% of the stock is currently owned by institutional investors and hedge funds.
United States Antimony Company Profile
United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.
See Also
- Five stocks we like better than United States Antimony
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- What Are Earnings Reports?
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for United States Antimony Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United States Antimony and related companies with MarketBeat.com's FREE daily email newsletter.
